Mitchell Lawrence Jones
Chief Medical Officer, PALISADE BIO, INC.
Companies
- PALISADE BIO, INC.Chief Medical Officer Sep 13, 2023 to now1
- PALISADE BIO, INC.Chief executive officer May 8, 2024 to May 8, 20242
- PALISADE BIO, INC.Chief financial officer May 8, 2024 to May 8, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- PALISADE BIO, INC. PALI94,009 shares3$125.5K at $1.33Jul 7, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 7, 2026Sold 51,880 shares at $2.05 of PALISADE BIO, INC.3
- Jul 6, 2026Exercised options 131,167 shares of PALISADE BIO, INC.3
- Feb 12, 2026Sold 1,989 shares at $1.75 of PALISADE BIO, INC.4
- Feb 11, 2026Exercised options 8,000 shares of PALISADE BIO, INC.4
- May 28, 2024Shares withheld for tax 461 shares at $4.76 of PALISADE BIO, INC.5
- May 28, 2024Exercised options 1,555 shares of PALISADE BIO, INC.5
- May 28, 2024Shares withheld for tax 810 shares at $4.76 of PALISADE BIO, INC.5
- May 28, 2024Exercised options 2,735 shares of PALISADE BIO, INC.5
- May 6, 2024Shares withheld for tax 47 shares at $8.46 of PALISADE BIO, INC.6
- May 6, 2024Exercised options 156 shares of PALISADE BIO, INC.6
- May 6, 2024Shares withheld for tax 90 shares at $8.46 of PALISADE BIO, INC.6
- May 6, 2024Exercised options 304 shares of PALISADE BIO, INC.6
- Feb 6, 2024Shares withheld for tax 2,153 shares at $0.44 of PALISADE BIO, INC.7
- Feb 6, 2024Exercised options 2,333 shares of PALISADE BIO, INC.7
- Feb 6, 2024Exercised options 4,558 shares of PALISADE BIO, INC.7
- Nov 7, 2023Shares withheld for tax 1,630 shares at $0.54 of PALISADE BIO, INC.8
- Nov 6, 2023Exercised options 4,556 shares of PALISADE BIO, INC.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 13, 2026
- 5SEC EDGARForm 4 filed May 30, 2024
- 6SEC EDGARForm 4 filed May 8, 2024
- 7SEC EDGARForm 4 filed Feb 8, 2024
- 8SEC EDGARForm 4 filed Nov 8, 2023